Published in:
01-06-2010 | Editorial
Making the Best of a Bad Situation: Early Chronic Nosocomial HCV infection
Authors:
Carmi Santos, Steven K. Herrine
Published in:
Digestive Diseases and Sciences
|
Issue 6/2010
Login to get access
Excerpt
As the hepatitis C epidemic enters its third decade, several trends have become evident: incidence has decreased, prevalence is leveling off, therapy is becoming more individualized, and developments in pharmacotherapy and pharmacogenomics promise to improve treatment outcomes. It is frustrating in this setting that although intravenous drug use continues to be the primary mode of transmission of hepatitis C virus (HCV) in the United States and Europe, nosocomial outbreaks of HCV infection continue to be reported [
1‐
3]. Such outbreaks are not new, having been extensively reported and analyzed in the setting of hemodialysis and poor infection control when using multidose saline vials, heparin solutions, and pain remediation treatments [
4‐
7]. …
